Alan Davis, PhD
Dr. Alan K. Davis is a Clinical Psychologist and Assistant Professor of Social Work and Psychiatry at Ohio State University. He is also on the faculty in the Department of Psychiatry at Johns Hopkins University. Alan has extensive clinical experience working with US Military Veterans and civilians suffering with addiction, PTSD, and depression. His research explores alternative treatments for addiction and mental illness, including psychedelic-assisted therapies, and how to increase access to current treatment systems through reducing provider stigma about substance misuse and alternative treatment approaches. Alan has published over 70 scientific articles and book chapters and presented research at dozens of national and international scientific conferences. Published landmark trial in 2021 on the use of psilocybin therapy for depression in JAMA psychiatry. In 2022, he is launching the Center for Psychedelic Drug Research and Education at Ohio State University, wherein he will conduct the first psilocybin therapy trial for Veterans with PTSD.
Financial: Dr. Alan Davis has employment relationships with Fluence, Ohio State University, and Johns Hopkins University. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Alan Davis serves on the grant review committee for the Source Research Foundation, as a member of the advisory board for Apollo Pact, Inc., and as chair of the Addiction Special Interest Group for the Society of Social Work and Research. He is a member of the American Psychological Association, the College on Problems of Drug Dependence, and the Society for Social Work Research. He is a consultant on the drug content moderator team for Meta.